Vaxil Bio Ltd
Vaxil Bio is a cutting-edge Israeli biotech focused on immuno-oncology as innovative cancer treatments. Vaxil's lead product, Immucin, has recently been granted "Orphan Drug Status" from both the FDA and the EMA agencies. Vaxil is based out of the Weizmann Science Park, Israel's top scientific institution, and was founded by Weizmann PhD Dr. Lior Carmon. The Company has completed a highly successful Phase-I/II in 15 Mutiple Myeloma patients, wherein 100% demonstrated robust immune responses, the results of which were published in the British Journal of Haematology Vaxil's patented platform, VaxHit, will protect the Company's ability to develop further cancer immunotherapy products utilizing the signal peptide domain of MUC1 which is present in 90% of cancers. Please visit for more information
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
4
11 to 50 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Vaxil Bio Ltd
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
Showing 1 of 2 verified contacts
Top roles at Vaxil Bio Ltd
2 distinct titles indexed · top 2 shown.
- 1controller
- 1seller
Sign up to unlock all 2 contacts at Vaxil Bio Ltd
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Vaxil Bio Ltd
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.